According to the recent research report titled ‘North America Vascular Graft Market Forecast 2027 By Application, By Raw Material, By End-use, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’ available with MarketStudyReport, North America vascular grafts market is projected to generate revenues worth USD 1 billion by 2027.

High prevalence of chronic renal disease and diabetes and the growing demand for hemodialysis has spiked the North America vascular grafts market growth in recent years.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4037683/  

For those unaware, circumventing a blocked or restricted artery to reinstate blood supply to an organ or extremity is referred to as vascular surgery. To construct an alternate pathway for blood flow, the surgeon uses a natural or synthetic graft to connect a healthier artery to the restricted artery beyond the blockage site.

The number of individuals requiring dialysis treatment for chronic renal disease is steadily increasing in the region. According to University of California, approximately 750,000 people in the country suffer from kidney failure every year, with an additional 2 million people worldwide. The renal vasculature is rebuilt with vascular grafts.

As a result, the rising incidence of end-stage renal dysfunction is expected to add significant traction to vascular grafts market size in North America.

The North America vascular grafts marketplace is segmented into application scope, raw material, end-use, and regional analysis.

In terms of application scope, the market is bifurcated into endovascular aneurysm repair, hemodialysis access, peripheral vascular repair, thoracic aortic aneurysm repair, and abdominal aortic aneurysms repair. The hemodialysis segment accounted for USD 240.7 million in 2020 and is expected to have remunerative growth through the forecast timeline.

Based on raw material this business space is divided into biosynthetic grafts, polyester grafts, polyurethane grafts, and EPTFE grafts. The polyester grafts segment is set to accumulate USD 646.4 million through 2027.

Moving forward with the end-user reach, the market is segregated into ambulatory surgical centers, hospitals, and others. The hospital segment held 62% of the market share in 2020 and is poised to grow substantially through the study timeframe, primarily due to an increase in the number of minimally invasive surgical process performed in hospitals.

The regional overview of the North America vascular grafts industry is spread across the U.S and Canada. Canada vascular graft market size is projected to expand at 5.7% CAGR through the forecast duration, given the increased pervasiveness of heart disorders in the country.

The leading players operating in the North America vascular grafts marketplace are B. Braun Melsungen, W.L. Gore and Associates Inc., Becton, Dickinson and Co. (C.R. Bard), Terumo Corporation, Cook Medical Inc., Endologix, Cryolife Inc., Getinge AB, Medtronic plc, and LeMaitre Vascular.